| Identification of project | EuroNanoMed 3 |
| Project number | 723770 |
| Type of Action | ERA-NET Cofund |
| Call | Horizon2020 |
| Duration | 66 months (November 1, 2016 – October 31, 2022) |
| Total Project Budget | €15,270,000.00 |
| Requested EU contribution | €5,039,100.00 |
| Coordinator | Spain – Institute of Health Carlos III (ISCIII) |
The project summary
EuroNanoMed is a platform for funding agencies and ministries established since 2008. National and Regional research funding programmes join together with the goal of creating and funding collaborative research and innovation projects that can convert research in nanotechnology into practical gains in medicine.
This project supports multidisciplinary and translational research and innovation projects that cover: Regenerative medicine, Diagnostics and Targeted delivery systems.
EuroNanoMed3 (2016-2021) is the new ERA-Net Cofund Action on Nanomedicine under Horizon 2020 that will build upon the achievements on its predecessors to support the European Nanomedicine research community.
Project activities
Project activities are divided into 10 work packages.
WP1: Project management
WP2: Call 2017 preparation and launch
WP3: Call 2017 evaluation and selection
WP4: Call 2017 project follow-up and monitoring
WP5: Communication, Exploitation and Dissemination of the results
WP6: Topic selection and definition (for calls 2018 and 2019)
WP7: Call 2018 preparation and launch
WP8: Call 2018 launch, evaluation and selection
WP9: Project follow-up and monitoring (for projects from all calls except Call 2017)
WP10: Project Seminars and Strategic Analysis
Participating organisations
- Instituto de Salud Carlos III (ISCIII), Spain
- Fonds de la Recherche Scientifique (FRS-FNRS), Belgium
- Sihtasutus Eesti Teadusagentuur (ETAg), Estonia
- Agence Nationale de la Recherche (ANR), France
- Bundesministerium für Bildung und Forschung (BMBF), Germany
- VDI Technologiezentrum GmbH (VDI), Germany
- Science Foundation Ireland (SFI), Ireland
- Ministry of Health, the Chief Scientist Office (CSO-MOH), Israel
- Italian Ministry of Health (IMH), Italy
- Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR), Italy
- State Education Development Agency (SEDA/VIAA), Latvia
- Research Council of Lithuania (RCL), Lithuania
- The Dutch Research Technology Foundation (STW), Netherlands
- Research Council of Norway (RCN), Norway
- National Centre for Research and Development (NCBR), Poland
- Fundação para a Ciência e a Tecnologia (FCT), Portugal
- National Authority for Scientific research (ANCS), Romania
- Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI), Romania
- Academie Slovaque des Sciences (SAS), Slovakia
- Centro para el Desarrollo Tecnológico Industrial (CDTI), Spain
- Ministerio de Economía y Competitividad (MINECO), Spain
- The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey
- General Secretariat for Research and Technology (GSRT), Greece
- Fonds de recherche du Québec – Santé (FRQS), Canada
- Ministry of Science and Technology (MoST), Taiwan
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 723770.